Fakten über Envision Pharma Group
Webseite | envisionpharmagroup.com |
Gegründet | 2001 |
Anzahl der Mitarbeiter | 501-1000 |
Branche | pharmaceuticals |
Land | US |
Stadt | west sussex |
Straßenadresse | -.33 |
Telefonnummer | (203) 254-3205 |
Email pattern | {first}.{last} |
Email Accept all Status | False |
Email Blocked Status | False |
Whois Erstellungsdatum | August 4th 2008, 10:16:42 am |
RWhois | www.easydns.com |
Whois Name | easyDNS Technologies Inc. |
Total Emails | 359 |
Total Personal Emails | 356 |
Total Generic Emails | 3 |
Last updated | July 27th 2023, 01:48:00 am |
Finden Sie die E-Mail von jedem hinter jeder Website
Soziale Konten von Envision Pharma Group
Alle E-Mail-Adressen für envisionpharmagroup.com
kim lealk***@envisionpharmagroup.com | senior hr assistant employee solutions | 2 Sources |
macaire montinim***@envisionpharmagroup.com | hr business partner | 2 Sources |
marsha caplinm***@envisionpharmagroup.com | Global Head, Multichannel | 2 Sources |
melissa hagmanm***@envisionpharmagroup.com | Client Portfolio Manager | 1 Sources |
ginny bernsteing***@envisionpharmagroup.com | Office Manager | 1 Sources |
thomas gegenyt***@envisionpharmagroup.com | Portfolio Team Lead, Scientific Solutions | 2 Sources |
mike kramerm***@envisionpharmagroup.com | technology solutions at envision pharma group | 2 Sources |
andria manninga***@envisionpharmagroup.com | operations manager | 2 Sources |
heather frankh***@envisionpharmagroup.com | Customer Care Portfolio Manager | 1 Sources |
kelli walkerk***@envisionpharmagroup.com | Portfolio Manager | 1 Sources |
349 mehr für Ihre Suche envisionpharmagroup.com
Erstellen Sie ein Konto, um die E-Mail-Adressen freizuschalten, erhalten Sie die vollständigen Ergebnisse, Suchfilter, CSV-Downloads und mehr.
E-Mail-Format
Pattern | # | |
---|---|---|
johndoe@envisionpharmagroup.com | {first}{last} | No |
john.doe@envisionpharmagroup.com | {first}.{last} | Available |
john-doe@envisionpharmagroup.com | {first}-{last} | No |
doejohn@envisionpharmagroup.com | {last}{first} | No |
doe.john@envisionpharmagroup.com | {last}.{first} | No |
doe-john@envisionpharmagroup.com | {last}-{first} | No |
jdoe@envisionpharmagroup.com | {f}{last} | No |
j.doe@envisionpharmagroup.com | {f}.{last} | No |
j-doe@envisionpharmagroup.com | {f}-{last} | No |
johnd@envisionpharmagroup.com | {first}{l} | No |
john.d@envisionpharmagroup.com | {first}.{l} | No |
john-d@envisionpharmagroup.com | {first}-{l} | No |
djohn@envisionpharmagroup.com | {l}{first} | No |
d.john@envisionpharmagroup.com | {l}.{first} | No |
d-john@envisionpharmagroup.com | {l}-{first} | No |
doej@envisionpharmagroup.com | {last}{f} | No |
doe.j@envisionpharmagroup.com | {last}.{f} | No |
doe-j@envisionpharmagroup.com | {last}-{f} | No |
john@envisionpharmagroup.com | {first} | No |
doe@envisionpharmagroup.com | {last} | No |
jd@envisionpharmagroup.com | {f}{l} | No |
j.d@envisionpharmagroup.com | {f}.{l} | No |
j-d@envisionpharmagroup.com | {f}-{l} | No |
dj@envisionpharmagroup.com | {l}{f} | No |
d.j@envisionpharmagroup.com | {l}.{f} | No |
d-j@envisionpharmagroup.com | {l}-{f} | No |